A Study of RBD1016 in CHB Participants

Clinical trial NCT05961098 · COMPLETED

Trial details

NCT number: NCT05961098
Sponsor: Suzhou Ribo Life Science Co. Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis b

Start date: 2023-10-11
Primary completion: 2025-04-29
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.